From: Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models
Target | Recombinant PCR-forward | Recombinant PCR-reverse | Recombinant PCR-reverse 2 |
---|---|---|---|
p53 | CACAAAAACAGGTTAAACCCA | GAAGACAGAAAAGGGGAGGG | |
Kras | GGGTAGGTGTTGGGATAGCTG | TCCGAATTCAGTGACTACAGATGTACAGAG | |
PTEN | ACTCAAGGCAGGGATGAGC | AATCTAGGGCCTCTTGTGCC | GCTTGATATCGAATTCCTGCAGC |
SMAD4 | TCCCACATTCCTCTTAGTTTTGA | CCAGCTTCTCTGTCCAGGTAGTA | |
PIK3CA | CACAGCTCGCGGTTGAGG | TGCTCGACGTTGTCACTGAA | CGGGTGTACTCCTCATATAACA |
TGFβR2 | AGGGATGAATGGGCTTGCTT | CTCACCTCAGAGCCTGATTA | |
TAK1 | GCAACTTCGACAACTTGCCTTCCTGTG | GCACTTGAATTAGCGGCCGCAAGCTTATAACT | |
EML-ALK | GAGCCTTGTTGATACATCGTTC | TAGGAGGCAGTTTGGGCTAC | CAAGGCAGTGAGAACCTGAA |